Facebook
Twitter
Telegram
Report an ErrorOnconova Therapeutics Balance Sheet 2011-2024 | ONTX
Annual Balance Sheet Onconova Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -19 M | -22.7 M | -17 M | -4.02 M | -21.4 M | -19.8 M | -43.6 M | -60 M | -81.5 M | -2.71 M |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 3.47 M | 3.81 M | 4.1 M | 5.86 M | 7.95 M | 5 M | 13.5 M | 13.9 M | 15.5 M | 131 M |
Total Current Liabilities |
9.22 M | 8.05 M | 6.12 M | 10 M | 8.29 M | 8.44 M | 9.98 M | 10.2 M | 7.6 M | 10.3 M | 10.3 M | - | - |
Total Liabilities |
12 M | 11.1 M | 9.36 M | 13.8 M | 12.1 M | 12.5 M | 15.8 M | 18.1 M | 12.6 M | 23.7 M | 24.3 M | 40.8 M | 143 M |
Deferred Revenue |
226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 455 K | 455 K | 455 K | 455 K | 788 K | 3.91 M | 455 K |
Retained Earnings |
-483 M | -464 M | -445 M | - | -403 M | -382 M | -362 M | -338 M | -319 M | -295 M | -231 M | -168 M | -138 M |
Total Assets |
22.7 M | 39.4 M | 55.5 M | 19.8 M | 23.7 M | 17.9 M | 4.98 M | 23.2 M | 23.4 M | 47.3 M | 105 M | 83.9 M | 4.46 M |
Cash and Cash Equivalents |
20.6 M | 38.8 M | 55.1 M | 19 M | 22.7 M | 17 M | 4.02 M | 21.4 M | 19.8 M | 43.6 M | 60 M | 81.5 M | 2.71 M |
Book Value |
10.7 M | 28.3 M | 46.1 M | 5.97 M | 11.6 M | 5.39 M | -10.9 M | 5.13 M | 10.8 M | 23.6 M | 80.9 M | 43 M | -138 M |
Total Shareholders Equity |
10.7 M | 28.3 M | 46.1 M | 6.18 M | 11.6 M | 5.39 M | -11.7 M | 4.3 M | 10 M | 22.7 M | 80.4 M | -158 M | -138 M |
All numbers in USD currency
Quarterly Balance Sheet Onconova Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
12.2 M | 12 M | 12.5 M | 11.6 M | 12.2 M | 11.1 M | 10.4 M | 9.59 M | 9.14 M | 9.36 M | 10.3 M | 11.4 M | 11.7 M | 13.8 M | 13.8 M | 13.8 M | 13.8 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 18.1 M | 18.1 M | 18.1 M | 18.1 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 24.3 M | 24.3 M | 24.3 M | 24.3 M | 40.8 M | 40.8 M | 40.8 M | - | - | - | - | - |
Deferred Revenue |
226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 226 K | 455 K | 455 K | 455 K | 455 K | 455 K | 455 K | 455 K | 455 K | 455 K | 455 K | 455 K | 455 K | 455 K | 455 K | 455 K | 455 K | 788 K | 788 K | 788 K | 788 K | 3.91 M | 3.91 M | 3.91 M | - | - | - | - | - |
Retained Earnings |
-488 M | -483 M | -478 M | -474 M | -469 M | -464 M | -458 M | -453 M | -449 M | -445 M | -441 M | -438 M | -433 M | -429 M | -429 M | -429 M | -429 M | -403 M | -403 M | -403 M | -403 M | -382 M | -382 M | -382 M | -382 M | -362 M | -362 M | -362 M | -362 M | -338 M | -338 M | -338 M | -338 M | -319 M | -319 M | -319 M | -319 M | -295 M | -295 M | -295 M | -295 M | -231 M | -231 M | -231 M | -231 M | -168 M | -168 M | -168 M | - | - | - | - | - |
Total Assets |
18.2 M | 22.7 M | 27 M | 30.5 M | 35.1 M | 39.4 M | 43.8 M | 48.1 M | 51.4 M | 55.5 M | 60 M | 44.4 M | 48.8 M | 20 M | 20 M | 20 M | 20 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 4.98 M | 4.98 M | 4.98 M | 4.98 M | 23.2 M | 23.2 M | 23.2 M | 23.2 M | 23.4 M | 23.4 M | 23.4 M | 23.4 M | 47.3 M | 47.3 M | 47.3 M | 47.3 M | 105 M | 105 M | 105 M | 105 M | 83.9 M | 83.9 M | 83.9 M | - | - | - | - | - |
Cash and Cash Equivalents |
16.4 M | 20.8 M | 25.2 M | 29.7 M | 34.2 M | 38.8 M | 42.6 M | 46.5 M | 50.8 M | 55.1 M | 59.4 M | 43.7 M | 48 M | 19 M | 19 M | 19 M | 19 M | 22.7 M | 22.7 M | 22.7 M | 22.7 M | 17 M | 17 M | 17 M | 17 M | 4.02 M | 7.6 M | 15 M | 15.4 M | 21.4 M | 25.8 M | 21.4 M | 21.4 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 43.6 M | 43.6 M | 43.6 M | 43.6 M | 60 M | 60 M | 60 M | 60 M | 81.5 M | 81.5 M | 81.5 M | - | 2.71 M | - | - | - |
Book Value |
6.02 M | 10.7 M | 14.5 M | 18.9 M | 22.9 M | 28.3 M | 33.4 M | 38.5 M | 42.3 M | 46.1 M | 49.7 M | 33 M | 37.2 M | 6.18 M | 6.18 M | 6.18 M | 6.18 M | 11.6 M | 11.6 M | 11.6 M | 11.6 M | 5.39 M | 5.39 M | 5.39 M | 5.39 M | -10.9 M | -10.9 M | -10.9 M | -10.9 M | 5.13 M | 5.13 M | 5.13 M | 5.13 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 80.9 M | 80.9 M | 80.9 M | 80.9 M | 43 M | 43 M | 43 M | - | - | - | - | - |
Total Shareholders Equity |
6.02 M | 10.7 M | 14.5 M | 18.9 M | 22.9 M | 28.3 M | 33.4 M | 38.5 M | 42.3 M | 46.1 M | 49.7 M | 33 M | 37.2 M | 6.18 M | 6.18 M | 6.18 M | 6.18 M | 11.6 M | -6.04 M | -4.55 M | -1.54 M | 5.39 M | 5.39 M | 5.39 M | 5.39 M | -11.7 M | -11.7 M | -11.7 M | -11.7 M | 4.3 M | 4.3 M | 4.3 M | 4.3 M | 10 M | 10 M | 10 M | 10 M | 22.7 M | 22.7 M | 22.7 M | 22.7 M | 80.4 M | 80.4 M | 80.4 M | 80.4 M | -158 M | -158 M | -158 M | - | -138 M | - | - | - |
All numbers in USD currency